Barr Pharmaceuticals

History

Barr Laboratories Inc. was founded in New York in 1970 by Edwin A. Cohen.

Starting in 1991 Barr Laboratories was involved in a scandal stemming from their violation of GMP regulations concerning handling of out-of-specification (OOS) test results. In 1993 Barr Labs lost a lawsuit stemming from these findings, resulting in new industry interpretations of FDA regulations regarding out of specification test results.

In 1993, Bruce L. Downey joined the company as its president and in 1994, he became chairman and chief executive officer of the company. In 1993, the company settled a patent infringement case and began distributing a generic version of tamoxifen citrate, a treatment for breast cancer.

In 1995, the company received approval to manufacture and sell a generic version of zidovudine (AZT), a treatment for AIDS. In 1996, the company became the first to receive approval from the Food and Drug Administration to market generic Warfarin, which was previously only sold by DuPont.

In 2001, the company acquired Duramed Pharmaceuticals for $589 million in stock. In August 2001, after a 5-year legal battle with Eli Lilly and Company, the company began selling a generic version of Prozac.

In 2003, the company acquired Endeavor Pharmaceuticals for $35 million. In 2004, the company acquired Women's Capital, maker of Plan B emergency contraceptives.

In October 2006, the company acquired Pliva. On December 23, 2008, the company was acquired by Teva Pharmaceutical Industries and became part of Teva Active Pharmaceutical Ingredients (TAPI).

References

References

1. "Barr Pharmaceuticals, Inc. 2007 Form 10-K Annual Report". [[U.S. Securities and Exchange Commission]].
2. "Teva buys Barr Pharmaceuticals". [[The Jerusalem Post]].
3. "Barr Pharmaceuticals, Inc. History". FundingUniverse.
4. "BARR LABS SHUTDOWN SOUGHT BY FDA DUE TO GMP VIOLATIONS UNCOVERED DURING AGENCY INSPECTIONS; FIRM CLAIMS FDA STANCE IS RETALIATION FOR WHISTLEBLOWING". PinkSheet.
5. (November 2007). "A History of the OOS Problem". Biopharm International.
6. (March 11, 2009). "Former Barr CEO Downey joins NewSpring Capital". [[American City Business Journals]].
7. (March 9, 1993). "PATENT SETTLEMENT LIFTS BARR LABORATORIES SHARES". [[The New York Times]].
8. (February 28, 1995). "BARR LABORATORIES WINS F.D.A. APPROVAL FOR GENERIC AZT". [[The New York Times]].
9. FOSS, KRISTA. (October 26, 2001). "BITTER PILL". [[The Globe and Mail]].
10. (June 30, 2001). "Barr to Buy Duramed in a Stock Swap". [[Los Angeles Times]].
11. PETERSEN, MELODY. (August 2, 2001). "Drug Maker Is Set to Ship Generic Prozac". [[The New York Times]].
12. (December 4, 2003). "COMPANY BRIEFS". [[The New York Times]].
13. (3 October 2003). "Company News; Barr Labs Agrees to Buy Assets of Women's Capital". Bloomberg.
14. (October 12, 2006). "Barr Acquires PLIVA d.d.". [[Pliva]].
15. (December 23, 2008). "TEVA COMPLETES ACQUISITION OF BARR". [[Pliva]].